Meetings

Insilico Medicine announced that its research paper, “When Single Answer Is Not Enough: Rethinking Single-Step Retrosynthesis Benchmarks for LLMs,” has been accepted for presentation at the International Conference on Machine Learning 2026. The study challenges conventional retrosynthesis benchmarking approaches that rely on single “ground-truth” answers and Top-K accuracy metrics, which may not reflect the multi-solution nature of real-world chemistry.

The paper introduces ChemCensor, a chemistry-aware evaluation metric designed to assess model performance based on reaction centers and functional groups, aligning more closely with expert human reasoning. Additional contributions include the CREED dataset, comprising 6.4 million validated reactions; benchmarking results from the C3LM model; and the URSA-expert-2026 dataset, an expert-annotated benchmark designed to reduce data leakage and improve evaluation rigor.

The research supports the development of more realistic and scalable training and evaluation frameworks for AI-driven retrosynthesis and drug discovery. Supporting materials will be made publicly available to promote transparency and reproducibility.

Targeting Phage Therapy 2026 will convene international leaders to accelerate clinical deployment, highlight innovation, and recognize excellence through the Targeting Phage Therapy Awards.

MONTREAL – APRIL 25, 2026 – Today, the Society for Cardiovascular Angiography & Interventions (SCAI) announced its 2026 Master Interventionalists of SCAI (MSCAI) designation recipients during the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit, held April 23-25, in Montréal, Canada.

MONTREAL – April 25, 2026 – The Society for Cardiovascular Angiography & Interventions (SCAI) today announced that Lauren Balkan, MD, has been selected as the recipient of the 2026–27 Women in Innovations (WIN) Complex and High-Risk Coronary Intervention (CHIP) Fellowship, a competitive award that supports the advancement of women in complex and high-risk coronary interventions. The announcement was made during the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit, held April 23–25, 2026, in Montréal, Canada.

MONTREAL – APRIL 25, 2026 – The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the selection of a new class of early-career interventional cardiologists to participate in the 2026–28 Emerging Leader Mentorship (ELM) Program. Participants will be recognized during the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit, held April 23–25 in Montréal, Canada. 

MONTREAL – APRIL 25, 2026 – The Society for Cardiovascular Angiography & Interventions (SCAI) today announced the recipients of the 2026 SCAI Early Career Research Grants (ECRGs), an initiative designed to support the next generation of academic interventional cardiologists. The announcement was made in conjunction with the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit, held April 23–25 in Montréal, Canada.

MONTREAL – APRIL 25, 2026 – At SCAI 2026 Scientific Sessions & CAIC-ACCI Summit, held April 23–25, in Montréal, Canada, the Society for Cardiovascular Angiography & Interventions (SCAI) recognized several individuals for their outstanding service, leadership, and contributions to patient care and to the field of interventional cardiology.

MONTREAL – APRIL 25, 2026 – The Society for Cardiovascular Angiography & Interventions (SCAI) today announced the recipients of its annual “30 in Their 30s” awards, honoring early-career interventional cardiologists who have demonstrated outstanding achievement, leadership, and dedication to the field. The honorees will be recognized during the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit, held April 23–25, in Montréal, Canada. 

MONTREAL – APRIL 25, 2026 – The Society for Cardiovascular Angiography & Interventions (SCAI) has announced J. Dawn Abbott, MD, MSCAI, as its President for 2026–27. Dr. Abbott will assume the role during SCAI 2026 Scientific Sessions, held April 23–25 in Montreal, Canada.

MONTREAL – April 24, 2026 – New data from the CDC WONDER database finds deaths from heart attack-related cardiogenic shock (CS) decreased between 1999 and 2020, but deaths linked to heart failure (HF) and abnormal heart rhythms have risen sharply since 2010, particularly among men. Researchers presented the findings today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2026 Scientific Sessions & Canadian Association of Interventional Cardiology/Association Canadienne de cardiologie d’intervention (CAIC-ACCI) Summit in Montreal.